The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
SLEEP 2026 | Obstructive sleep apnea and Alzheimer’s disease risk: toward personalized care
Omonigho Michael Bubu, MD, MPH, PhD, NYU Grossman School of Medicine, New York City, NY, discusses how obstructive sleep apnea (OSA) may contribute to Alzheimer’s disease risk through mechanisms including sleep fragmentation, intermittent hypoxia, and reduced sleep duration. He explains how these factors may affect different racial, ethnic, and sex groups differently, and highlights the potential for more personalized approaches to OSA assessment and management. This interview took place at the 40th annual meeting of the Associated Professional Sleep Societies (APSS) in Baltimore, MD.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
